- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00917176
Occipital Nerve Stimulation in Fibromyalgia
June 9, 2009 updated by: University Hospital, Antwerp
Subcutaneous C2 Stimulation: Treatment of Fibromyalgia
The aim of this study is to investigate whether greater occipital nerve stimulation is effective in the treatment of fibromyalgia related pain.
The study uses sub sensory threshold stimulation and placebo stimulation in order to investigate whether sub-threshold stimulation is feasible in a placebo controlled study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Edegem, Belgium, 2650
- University Hospital Antwerp
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Diagnosed according to the criteria of the American College of Rheumatology (ACR-90)
- Minimally treated with adequate trials during 3 months
- Insight of the patient in her disease and capable of understanding and signing an informed consent
Exclusion Criteria:
- History of severe illness or suffering from severe chronic disease
- History of substance abuse, unless treated and in remission during 6 months
- Cardiac disease
- History of epileptic insults
- Psychiatric disorders with psychotic symptoms
- Pace maker / defibrillator
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Effective stimulation
Effective stimulation at sub-threshold level
|
|
|
Placebo Comparator: Placebo stimulation
Stimulation at non-effective strength
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain scores on Visual Analogue Scale (VAS), pain Catastrophizing Scale (PCS), pain vigilance and awareness questionnaire (PVAQ)
Time Frame: at a weekly base during 10 weeks
|
at a weekly base during 10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Scores on Fatigue and Mood
Time Frame: at a weekly base, during 10 weeks
|
at a weekly base, during 10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Dirk De Ridder, M.D., PhD., University Hospital, Antwerp
- Principal Investigator: Mark Plazier, M.D., University Hospital, Antwerp
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
June 9, 2009
First Submitted That Met QC Criteria
June 9, 2009
First Posted (Estimate)
June 10, 2009
Study Record Updates
Last Update Posted (Estimate)
June 10, 2009
Last Update Submitted That Met QC Criteria
June 9, 2009
Last Verified
June 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMS_ONS_01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on Occipital nerve stimulation
-
IRCCS Sacro Cuore Don Calabria di NegrarCompleted
-
MedtronicNeuroCompletedChronic Migraine HeadacheUnited States, Canada, United Kingdom
-
Yale UniversityNot yet recruiting
-
Centre Hospitalier Universitaire de NiceCompleted
-
Nantes University HospitalTerminatedOccipital NeuralgiaFrance
-
Butler HospitalUniversity of North Carolina, Chapel Hill; Neurolief Ltd.Active, not recruiting
-
Aydin Adnan Menderes UniversityActive, not recruitingRadiofrequency Ablation | Chronic Migraine Headache | Greater Occipital Nerve Block | Calcitonin Gene-related Peptide | Pacap-38Turkey (Türkiye)
-
Leiden University Medical CenterUniversity of Copenhagen; Maastricht University Medical Center; Erasmus Medical... and other collaboratorsCompletedChronic Cluster HeadacheNetherlands, Belgium, Germany, Hungary
-
Diskapi Teaching and Research HospitalActive, not recruitingMigraine Disorders | Headache Migraine ChronicTurkey
-
Keimyung University Dongsan Medical CenterRecruiting